JIMD Reports - Case and Research Reports, 2012/3 pp 127-129

Part of the JIMD Reports book series (JIMD, volume 6)

Successful Weight Loss in Two Adult Patients Diagnosed with Late-Onset Long-Chain Fatty Acid Oxidation Defect

  • H. Zweers
  • C. Timmer
  • E. Rasmussen
  • M. den Heijer
  • H. de Valk
Case Report

Abstract

Patients with long-chain fatty acid oxidation defect (LCFAOD) cannot tolerate fasting and are restricted in their physical activity, hence their increased risk of obesity. Experts therefore advise avoidance of catabolic situations and discourage weight reduction in these patients.

Two patients with late-diagnosed LCFAOD undergoing treatment at two academic centers successfully lost weight under supervision of a metabolic dietitian. Patient 1 (male, 47 years) diagnosed with CPT 2 deficiency lost 10 kg body weight in a 3-month period with the help of an energy and LCT-restricted, MCT- and carbohydrate-rich diet in combination with an exercise program. CK levels, C16, C18, and C18:1 levels of his acylcarnitine profile and his blood pressure decreased during the period of weight reduction. Patient 2 (male, 39 years) has a VLCAD deficiency. Dietary advice was energy and LCT restriction, MCT and carbohydrate-enriched food with raw cornstarch added during the night. Patient 2 lost almost 40 kg body weight to 87.6 kg (BMI 25.1) in 2 years. CK, insulin, TG, and ALAT blood levels decreased. Conclusion: Weight reduction without loss of metabolic control seems possible in late-onset LCFAOD patients. No metabolic crisis occurred in these two patients, while the positive effects of weight reduction were clear. The residual enzyme function in late-onset LCFAOD may be one of the reasons that metabolic decompensation was prevented. In addition, dietary adjustments to prevent excessive fatty acid oxidation likely contributed as well. Therefore, expert supervision by a dietician specialized in metabolic diseases is recommended.

Concise SentenceContrary to the current literature, weight loss in patients with late-diagnosed LCFAOD can be successful. A description of two FOAD patients who lost weight without encountering negative side effects at two academic centers is given.

Abbreviations

ALAT

Alanine-aminotransferase

BMI

Body mass index

BP

Blood pressure

CK

Creatine kinase

CPT 2

Carnitine palmitoyl-CoA transferase 2

FAOD

Fatty acid oxidation defect

LCFAOD

Long-chain fatty acid oxidation defect

LCT

Long-chain triglycerides (long-chain fat)

MCT

Medium-chain triglycerides

TG

Triglycerides (fat)

VLCAD

Very long-chain acyl-CoA dehydrogenase

References

  1. Behrend AM, Harding CO, Shoemaker JD, Matern D, Sahn DJ, Elliot DL, Gillingham MB (2011) Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation. Mol Genet Metab 105(2012):110–115Google Scholar
  2. Gillingham MB, Purnell JQ, Jordan J, Stadler D, Haqq AM, Harding CO (2007) Effects of higher dietary protein intake on energy balance and metabolic control in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. Mol Genet Metab 90(1):64–69PubMedCrossRefGoogle Scholar
  3. Laforêt P, Vianey-Saban C (2010) Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges. Neuromuscul Disord 11:693–700CrossRefGoogle Scholar
  4. Roza AM, Shizgal HM (1984) The Harris Benedict reevaluated: resting energy requirement and body cell mass. Am J Clin Nutr 40:168–182PubMedGoogle Scholar
  5. Spiekerkoetter U et al (2009) Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis 32:498–505PubMedCrossRefGoogle Scholar
  6. Spiekerkoetter U et al (2010) Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. J Inherit Metab Dis 33:555–561PubMedCrossRefGoogle Scholar

Copyright information

© SSIEM and Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • H. Zweers
    • 1
  • C. Timmer
    • 2
  • E. Rasmussen
    • 1
  • M. den Heijer
    • 1
  • H. de Valk
    • 2
  1. 1.Department of Gastroenterology and Hepatology-DieteticsRadboud University Nijmegen Medical CentreNijmegenThe Netherlands
  2. 2.University Medical Center UtrechtUtrechtThe Netherlands

Personalised recommendations